Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Liver Diseases × Catheter Ablation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Malignant Liver Neoplasm 1 Liver Diseases 1 Carcinoma, Hepatocellular 1

Interventions

atezolizumab 2 Sorafenib 2 Bevacizumab 2 titanium silicide 1 ledipasvir, sofosbuvir drug combination 1 halofantrine 1 genexol-PM 1 durvalumab 1 Sunitinib 1 Ramucirumab 1 Neoadjuvant Therapy 1 N-monoacetylcystine 1 Leucovorin 1 Injections 1 Immunotherapy 1 Formyltetrahydrofolates 1 Everolimus 1 Cisplatin 1 Catheter Ablation 1 Adjuvants, Pharmaceutic 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04727307 2025-09-30

AB-LATE02

University Hospital, Montpellier

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡